Xeris Biopharma Holdings, Inc. (0A8E.L)

USD 3.29

(-4.76%)

Eps Summary of Xeris Biopharma Holdings, Inc.

  • Xeris Biopharma Holdings, Inc.'s latest annual eps in 2024 was -0.45 USD , up 35.71% from previous year.
  • Xeris Biopharma Holdings, Inc.'s latest quarterly eps in 2024 FY was N/A , up 35.71% from previous quarter.
  • Xeris Biopharma Holdings, Inc. reported an annual eps of -0.70 USD in 2023, up 41.67% from previous year.
  • Xeris Biopharma Holdings, Inc. reported an annual eps of -1.20 USD in 2022, up 58.33% from previous year.
  • Xeris Biopharma Holdings, Inc. reported a quarterly eps of N/A for 2024 FY, up 35.71% from previous quarter.
  • Xeris Biopharma Holdings, Inc. reported a quarterly eps of -0.14 USD for 2024 Q3, down -44.48% from previous quarter.

Annual Eps Chart of Xeris Biopharma Holdings, Inc. (2024 - 2017)

Historical Annual Eps of Xeris Biopharma Holdings, Inc. (2024 - 2017)

Year Eps Eps Growth
2024 -0.45 USD 35.71%
2023 -0.70 USD 41.67%
2022 -1.20 USD 58.33%
2021 -2.88 USD 17.48%
2020 -3.49 USD 30.06%
2019 -4.99 USD 61.88%
2018 -13.09 USD -82.57%
2017 -7.17 USD 0.0%

Peer Eps Comparison of Xeris Biopharma Holdings, Inc.

Name Eps Eps Difference
Arrowhead Pharmaceuticals, Inc. -1.91 USD 76.44%
Codexis, Inc. -1.12 USD 59.821%
Viridian Therapeutics, Inc. -5.31 USD 91.525%
Organovo Holdings, Inc. -1.60 USD 71.875%